Ownership

13F as of Q2 2026 · 1.7M shares outstanding

Who owns ADVB?

By type of holder

Institutions 0.0% Insiders 0.0% Everyone else 100.0%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Advanced Biomed Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2026

+0.2%

+0.11% a year

Each share's claim on the business

−0.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.73M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding ADVB.

Super Investors

Investment managers reporting ADVB on Form 13F

No 13F manager reports holding ADVB yet.

Institutional Funds

Mutual funds and ETFs reporting ADVB on Form N-PORT; together they hold 1.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FN Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust	$209K	22.1K	1.34%	0.00%	August 31, 2026

Fidelity Nasdaq Composite Index Fund

Fidelity Concord Street Trust

Position value

$209K

% of company

1.34%

% of the fund

0.00%

As of

August 31, 2026

Comments